Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors

Bioorg Med Chem Lett. 2000 May 15;10(10):1069-72. doi: 10.1016/s0960-894x(00)00170-0.

Abstract

A new class of conformationally constrained thrombin inhibitors is described. These compounds contain a unique bicyclic pyridone scaffold which serves as a P3P2 dipeptide surrogate. The synthesis and antithrombotic activity of these inhibitors is reported.

MeSH terms

  • Acetamides / chemistry*
  • Acetamides / pharmacology*
  • Aminopyridines / chemistry*
  • Aminopyridines / pharmacology*
  • Animals
  • Anticoagulants / chemical synthesis
  • Anticoagulants / chemistry*
  • Anticoagulants / pharmacology*
  • Biological Availability
  • Dipeptides / chemistry
  • Dogs
  • Drug Design
  • Drug Evaluation, Preclinical / methods
  • Humans
  • Molecular Mimicry
  • Pyridones / chemistry
  • Pyridones / pharmacology
  • Rats
  • Structure-Activity Relationship
  • Thrombin / antagonists & inhibitors*
  • Thrombosis / drug therapy

Substances

  • Acetamides
  • Aminopyridines
  • Anticoagulants
  • Dipeptides
  • Pyridones
  • Thrombin